Susquehanna International Group, LLP Prothena Corp Public LTD CO Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Susquehanna International Group, LLP holds 47,433 shares of PRTA stock, worth $705,803. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,433
Previous 33,790
40.38%
Holding current value
$705,803
Previous $697,000
13.77%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding PRTA
# of Institutions
184Shares Held
42.7MCall Options Held
162KPut Options Held
102K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$172 Million8.41% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$62.2 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$57.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$56.9 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$25.9 Million4.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $698M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...